Posted February 21, 2020
Three research teams have received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), a global public-private partnership launched at the Davos World Economic Forum in 2017, to develop a vaccine for the new strain of coronavirus (2019-nCoV). Read more.